Japanese study shows mRNA injections are associated with poorer outcomes for patients with pancreatic cancer
By Rhoda Wilson on April 23, 2025
A Japanese study found that repeated covid mRNA vaccinations are associated with poorer overall survival in patients with pancreatic cancer. The pre-print study was published on 15 April.
The following day, the World Health Organisation (“WHO”) finalised a draft for an international pandemic agreement, which includes promoting the sharing of mRNA vaccines. The draft is set to be adopted by “representatives” from WHO member countries at the World Health Assembly next month.
In what should be a shocking move but is no longer, WHO is pushing forward with its agenda despite the ever-growing evidence of serious adverse effects and higher death rates following mRNA vaccination.
Landmark Study Finds Repeated mRNA Vaccination Increases Vulnerability to Cancer Progression
By Dr. Guy Hatchard, 19 April 2025
This article goes deeply into the principles of the laws of nature governing life everywhere, it presents fundamental problems outlined in recently published scientific papers and then suggests the solution.
Fortunately, some responsible scientists around the world are continuing to investigate the fallout from the global mRNA covid-19 vaccination programme which delivered 13 billion doses in total.
Japanese scientists have completed a study of the effect of covid-19 vaccination on Pancreatic Cancer (“PC”) patients in their hospital system entitled ‘Repeated Covid-19 Vaccination as a Poor Prognostic Factor in Pancreatic Cancer: A Retrospective, Single-Centre Cohort Study’. The study is having a global impact; within a day of its publication, it has already been downloaded 4,000 times.
The study begins with the obligatory homage to mRNA technology damning it with faint praise as “a significant technological advance,” which is a misrepresentation still necessary to ensure the paper’s acceptance for publication (yes, journals are still clinging on to the fantasy).
It then plunges into the detailed story of cancer vulnerability. It examined the impact of covid-19 vaccinations on the survival of 272 PC patients in their hospital admitted between January 2018 and November 2023.
Pancreatic cancer is an aggressive cancer with a low survival rate (about 10-12% after 5 years). It is often detected at a late stage when it is already invading nearby structures, eventually metastasising to other parts of the body. The Japanese study found that repeated covid-19 booster vaccinations are associated with poorer overall survival in patients with PC.
more:
https://expose-news.com/2025/04/23/mrna-injections-and-poorer-patient-outcomes/